Soerensen AV, Geertsen PF, Christensen IJ, Hermann GG, Jensen NV, Fode K, et al. A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2. AO [Internet]. 2016 Mar. 3 [cited 2024 Nov. 11];55(3):341-8. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25232